INmune Bio, Inc. (INMB) Tops Q1 EPS by 18c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.36), $0.18 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $38 thousand.

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• Barclays says AI trade is maturing, favors greater diversification